Kalshi· Science and Technology

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027?

Chance

64%

Buy Yes

66¢

pays $1 if it happens

Buy No

39¢

pays $1 if it doesn’t

Prices from Kalshi, updated 1 minute ago. Ends Mar 1, 4:59 AM UTC.

Price over the last 2 weeks

Cost of a Yes share

How this market is decidedShow

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.